About: Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS‐CoV‐2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS‐CoV‐2 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS‐CoV‐2
Creator	Cabanillas, Beatriz Novak, Natalija
source	Medline; PMC
abstract	Viral infections and atopic diseases are closely related and contribute to each other. The physiological deficiencies and immune mechanisms that underlie atopic diseases can result in a suboptimal defense against multiple viruses and promote a suitable environment for their proliferation and dissemination. Viral infections, on the other hand, can induce per se several immunological mechanisms involved in allergic inflammation capable to promote the initiation or exacerbation of atopic diseases such as atopic asthma. In a world that is affected more and more by factors that significantly impact the prevalence of atopic diseases, coronavirus disease 2019 (COVID‐19) induced by the novel coronavirus severe acute respiratory syndrome (SARS‐CoV‐2) is having an unprecedented impact with still unpredictable consequences. Therefore, it is of crucial importance to revise the available scientific literature regarding the association between common respiratory viruses and asthma, as well as the newly emerging data about the molecular mechanisms of SARS‐CoV‐2 infection and its possible relation with asthma, to better understand the interrelation between common viruses and asthma and its potential meaning on the current global pandemic of COVID‐19.
has issue date	2020-07-20(xsd:dateTime)
bibo:doi	10.1111/imm.13240
bibo:pmid	32687609
has license	no-cc
sha1sum (hex)	0916f5db2db8fc74fa8da81e46b10ace34128376
schema:url	https://doi.org/10.1111/imm.13240
resource representing a document's title	Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS‐CoV‐2
has PubMed Central identifier	PMC7405154
has PubMed identifier	32687609
schema:publication	Immunology
resource representing a document's body	covid:0916f5db2db8fc74fa8da81e46b10ace34128376#body_text
is schema:about of	named entity 'RSV' named entity 'asthma' named entity 'metapneumovirus' named entity 'Th2' named entity 'viruses' named entity 'epidemiologic studies' named entity 'IFN' named entity 'viruses' named entity 'homeostasis' named entity 'viruses' named entity 'cellular level' named entity 'sequelae' named entity 'TSLP' named entity 'COVID' named entity 'Picornaviradae' named entity 'asthma' named entity 'COVID-19' named entity 'type I interferons' named entity 'asthma' named entity 'Paramyxoviradae' named entity 'receptor' named entity 'acute asthma' named entity 'IL-33' named entity 'Respiratory allergy' named entity 'viruses' named entity 'cytokines' named entity 'neonatal' named entity 'lungs' named entity 'cell injury' named entity 'general population' named entity 'RSV' named entity 'China' named entity 'wheezing' named entity 'viruses' named entity 'adaptive immunity' named entity 'synergistically' named entity 'immune cells' named entity 'risk factor' named entity 'immune cells' named entity 'interact' named entity 'IgE' named entity 'IL-25' named entity 'viruses' named entity 'ciliated cells' named entity 'chemotaxis' named entity 'IL-5' named entity 'asthma' named entity 'asthma' named entity 'epithelial' named entity 'viruses' named entity 'lung function' named entity 'pattern recognition receptors' named entity 'IL-13' named entity 'COVID' named entity 'viruses' named entity 'eosinophils' named entity 'IgE' named entity 'interact' named entity 'diabetes mellitus' named entity 'type 2' named entity 'inflammatory factors' named entity 'asthmatic' named entity 'asthma exacerbations' named entity 'allergic inflammation' named entity 'IL-33' named entity 'mucus' named entity 'asthma' named entity 'asthmatic' named entity 'asthmatic' named entity 'lung' named entity 'IL-33' named entity 'asthmatic' named entity 'mouse model' named entity 'LAD2' named entity 'inflammation' named entity 'HDM' named entity 'antiviral' named entity 'lung inflammation' named entity 'hyperinflammation' named entity 'immune response'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software